Klettner Alexa
Department of Ophthalmology, University Medical Center, University of Kiel, 24105 Kiel, Germany.
Mar Drugs. 2016 Feb 3;14(2):31. doi: 10.3390/md14020031.
Fucoidan is a heterogeneous group of sulfated polysaccharide with a high content of l-fucose, which can be extracted from brown algae and marine invertebrates. It has many beneficial biological activities that make fucoidan an interesting candidate for therapeutic application in a variety of diseases. Age-related macular degeneration and diabetic retinopathy are major causes for vision loss and blindness in the industrialized countries and increasingly in the developing world. Some of the characteristics found in certain fucoidans, such as its anti-oxidant activity, complement inhibition or interaction with the Vascular Endothelial Growth factor, which would be of high interest for a potential application of fucoidan in age-related macular degeneration or diabetic retinopathy. However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological activities of fucoidan that could be of interest regarding these diseases will be discussed.
岩藻依聚糖是一类富含L-岩藻糖的硫酸化多糖的异质群体,可从褐藻和海洋无脊椎动物中提取。它具有许多有益的生物活性,这使得岩藻依聚糖成为治疗多种疾病的有趣候选物。年龄相关性黄斑变性和糖尿病视网膜病变是工业化国家以及越来越多发展中国家视力丧失和失明的主要原因。某些岩藻依聚糖所具有的一些特性,例如其抗氧化活性、补体抑制作用或与血管内皮生长因子的相互作用,这对于岩藻依聚糖在年龄相关性黄斑变性或糖尿病视网膜病变中的潜在应用具有很高的价值。然而,迄今为止,岩藻依聚糖在眼科疾病中的可能用途很少受到关注。在这篇综述中,将讨论岩藻依聚糖与这些疾病相关的可能具有重要意义的生物活性。